![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Alzheimer's Disease |
Free Subscription
5 Alzheimer Dis Assoc Disord |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous
Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing.
Alzheimer Dis Assoc Disord. 2023;37:164-167.
PubMed
Abstract available
Caregiver Burden and Quality of Life Across Alzheimer's Disease Severity Stages.
Alzheimer Dis Assoc Disord. 2023;37:134-141.
PubMed
Abstract available
Remuneration and Recruitment of Study Participants for AD Cohort Studies From the
General Public and From Minority Communities.
Alzheimer Dis Assoc Disord. 2023;37:107-112.
PubMed
Abstract available
A Virtual Photovoice Study of Older African Americans Perceptions of
Neurovascular Clinical Trials.
Alzheimer Dis Assoc Disord. 2023;37:113-119.
PubMed
Abstract available
MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes.
Alzheimer Dis Assoc Disord. 2023;37:152-155.
PubMed
Abstract available
Levels of Alzheimer's disease blood biomarkers are altered after food intake-A
pilot intervention study in healthy adults.
Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13163.
PubMed
Abstract available
Learning slopes in early-onset Alzheimer's disease.
Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13159.
PubMed
Abstract available
Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new
catalogue of disease candidate short structural variants.
Alzheimers Dement. 2023 May 30. doi: 10.1002/alz.13168.
PubMed
Abstract available
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's
Disease Study (LEADS) cohort near the midpoint of data collection.
Alzheimers Dement. 2023 May 31. doi: 10.1002/alz.13160.
PubMed
Abstract available
Novel loci for Alzheimer's disease identified by a genome-wide association study
in Ashkenazi Jews.
Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13117.
PubMed
Abstract available
Fc N-glycosylation of autoreactive Abeta antibodies as a blood-based biomarker for
Alzheimer's disease.
Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13124.
PubMed
Abstract available
Higher concentrations of kynurenic acid in CSF are associated with the slower
clinical progression of Alzheimer's disease.
Alzheimers Dement. 2023 Jun 2. doi: 10.1002/alz.13162.
PubMed
Abstract available
Am J Alzheimers Dis Other Demen
Quality of Life Ratings and Proxy Bias in Primary Progressive Aphasia: Two Sides
to the Story?
Am J Alzheimers Dis Other Demen. 2023;38:15333175231177668.
PubMed
Abstract available
When Alzheimer's is LATE: Why does it matter?
Ann Neurol. 2023 May 28. doi: 10.1002/ana.26711.
PubMed
Abstract available
Decreased Cerebrospinal Fluid Amyloid beta 38, 40, 42, and 43 Levels in Sporadic and
Hereditary Cerebral Amyloid Angiopathy.
Ann Neurol. 2023;93:1173-1186.
PubMed
Abstract available
Deep venous thrombosis and hyponatremia associated with citalopram use for
behavioral symptoms in Parkinson's disease: a case report.
BMC Geriatr. 2023;23:344.
PubMed
Abstract available
A systematic review and meta-analysis on the efficacy outcomes of selective
serotonin reuptake inhibitors in depression in Alzheimer's disease.
BMC Neurol. 2023;23:210.
PubMed
Abstract available
Pathological combinations in neurodegenerative disease are heterogeneous and
disease-associated.
Brain. 2023;146:2557-2569.
PubMed
Abstract available
Sex-dependent effects of acute stress on amyloid-beta in male and female mice.
Brain. 2023;146:2268-2274.
PubMed
Abstract available
Randomizing for Alzheimer's disease drug trials should consider the cancer
history of participants.
Brain. 2023 May 27:awad177. doi: 10.1093.
PubMed
Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype.
Brain. 2023 May 31:awad184. doi: 10.1093.
PubMed
Abstract available
Correction: The most valuable player or the tombstone: is tau the correct target
to treat Alzheimer's disease?
Brain. 2023 Jun 1:awad176. doi: 10.1093.
PubMed
Putative pathological mechanisms of late-life depression and Alzheimer's disease.
Brain Res. 2023;1813:148423.
PubMed
Abstract available
Outcomes and Factors Affecting Transcranial Direct Current Stimulation in
Alzheimer's Disease Patients: A Systematic Review.
Curr Alzheimer Res. 2023 Jun 1. doi: 10.2174/1567205020666230601095957.
PubMed
Abstract available
Is Vitamin D Supplementation a danger to potential treatments of Alzheimer's
Disease Treatment?
Curr Alzheimer Res. 2023 May 30. doi: 10.2174/1567205020666230530095421.
PubMed
Landmark Model-Based Individual Dynamic Prediction of Conversion from Mild
Cognitive Impairment to Alzheimer's Disease using Cognitive Screening.
Curr Alzheimer Res. 2023 May 26. doi: 10.2174/1567205020666230526101524.
PubMed
Abstract available
Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's
Disease.
J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230142.
PubMed
Abstract available
Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal
Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort.
J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221274.
PubMed
Abstract available
Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and
Spatial Cognition in Alzheimer's Disease Mice.
J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-221245.
PubMed
Abstract available
APP/PS1 Gene-Environmental Cadmium Interaction Aggravates the Progression of
Alzheimer's Disease in Mice via the Blood-Brain Barrier, Amyloid-beta, and
Inflammation.
J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221205.
PubMed
Abstract available
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic
Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-221026.
PubMed
Abstract available
The Multifactorial Etiopathogenesis of Alzheimer's Disease: Neuroinflammation as
the Major Contributor.
J Alzheimers Dis. 2023 May 20. doi: 10.3233/JAD-230150.
PubMed
Abstract available
Advancing Diagnostic Certainty in Alzheimer's Disease: A Synthesis of the
Diagnostic Process.
J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230186.
PubMed
Abstract available
The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related
Cognitive Impairment: A Systematic Review and Meta-Analysis.
J Alzheimers Dis. 2023 May 23. doi: 10.3233/JAD-230406.
PubMed
Abstract available
Passive digital markers for Alzheimer's disease and other related dementias: A
systematic evidence review.
J Am Geriatr Soc. 2023 May 30. doi: 10.1111/jgs.18426.
PubMed
Abstract available
Interplay of lipid head group and packing defects in driving
amyloid-beta-mediated myelin-like model membrane deformation.
J Biol Chem. 2023;299:104653.
PubMed
Abstract available
Different transmembrane domains determine the specificity and efficiency of the
cleavage activity of the gamma-secretase subunit presenilin.
J Biol Chem. 2023;299:104626.
PubMed
Abstract available
Rapid, scalable assay of amylin-beta amyloid co-aggregation in brain tissue and
blood.
J Biol Chem. 2023;299:104682.
PubMed
Abstract available
Brain iron acquisition: An overview of homeostatic regulation and disease
dysregulation.
J Neurochem. 2023;165:625-642.
PubMed
Abstract available
Postsynaptic protein Shank3a deficiency synergizes with Alzheimer's disease
neuropathology to impair cognitive performance in the 3xTg-AD murine model.
J Neurosci. 2023 May 30:JN-RM-1945-22. doi: 10.1523/JNEUROSCI.1945-22.2023.
PubMed
Abstract available
Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical
Alzheimer's disease.
Nat Med. 2023 May 29. doi: 10.1038/s41591-023-02380.
PubMed
Abstract available
beta(2)-Microglobulin coaggregates with Abeta and contributes to amyloid pathology and
cognitive deficits in Alzheimer's disease model mice.
Nat Neurosci. 2023 Jun 1. doi: 10.1038/s41593-023-01352.
PubMed
Abstract available
Single-nucleus multiregion transcriptomic analysis of brain vasculature in
Alzheimer's disease.
Nat Neurosci. 2023 Jun 1. doi: 10.1038/s41593-023-01334.
PubMed
Abstract available
beta2-Microglobulin boosts beta-amyloid aggregation and neurotoxicity in an Alzheimer's
disease model.
Nat Neurosci. 2023 Jun 1. doi: 10.1038/s41593-023-01354.
PubMed
Oligomeric tau might spread trans-synaptically in Alzheimer disease.
Nat Rev Neurosci. 2023 May 26. doi: 10.1038/s41583-023-00714.
PubMed
Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer's disease.
Nature. 2023 May 31. doi: 10.1038/s41586-023-06120.
PubMed
Abstract available
Association of Stages of Objective Memory Impairment With Incident Symptomatic
Cognitive Impairment in Cognitively Normal Individuals.
Neurology. 2023;100:e2279-e2289.
PubMed
Abstract available
Clostridium butyricum improves cognitive dysfunction in ICV-STZ-induced
Alzheimer's disease mice via suppressing TLR4 signaling pathway through the
gut-brain axis.
PLoS One. 2023;18:e0286086.
PubMed
Abstract available
Early chronic suppression of microglial p38alpha in a model of Alzheimer's disease
does not significantly alter amyloid-associated neuropathology.
PLoS One. 2023;18:e0286495.
PubMed
Abstract available
Design and synthesis of multi-functional small-molecule based inhibitors of
amyloid-beta aggregation: Molecular modeling and in vitro evaluation.
PLoS One. 2023;18:e0286195.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by